• Explore /
  • Poster
  • / A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).

A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).

Abstract Poster

Authors

null

Andrea Cercek

Memorial Sloan Kettering Cancer Center, New York, NY

Andrea Cercek , Nancy E. Kemeny , Thomas Boerner , Benjamin R. Tan Jr., Joanne F. Chou , Mithat Gonen , Taryn Mary Boucher , Haley Hauser , Richard K. G. Do , Maeve Aine Lowery , Peter Kingham , Michael Ian D'Angelica , Jeffrey A. Drebin , Peter J. Allen , Neeta Vachharajani , Maria Majella Doyle , Ryan Fields , William G. Hawkins , William C. Chapman , William R. Jarnagin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT01862315

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4092)

DOI

10.1200/JCO.2018.36.15_suppl.4092

Abstract #

4092

Poster Bd #

281

Abstract Disclosures

Similar Posters

First Author: Jonathan Matthew Hernandez

First Author: Brett S Walker

First Author: Patrick Grierson

First Author: Agustin Pimentel